Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Star
8481.5000
4.50
(
0.05
%)
NSE
Aug 17, 2026
15:31 PM
New 52W High in past week
Volume:
252.0K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
04 Feb 2025
8481.50
0.05%
DIVI'S LABORATORIES
Accumulate:
Divi's Laboratories Ltd.
by
Prabhudas Lilladhar
Target: 6250
Recommendation
Target
Prabhudas Lilladhar
Divi's Laboratories .. has an
average target
of 7062.83 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended
IPO market heats up as Blackstone-backed Horizon leads a crowded mainboard calendar
|
17 Aug 2026, 05:50PM
Market closes lower as oil trades near $89 amid US-Iran deadlock
Trendlyne Marketwatch |
17 Aug 2026, 03:58PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022